Targeting cancer-associated fibroblasts with hydroxyethyl starch nanomedicine boosts cancer therapy

被引:0
作者
Chong Wang
Huimin Wang
Hai Yang
Chen Xu
Qiang Wang
Zheng Li
Zhijie Zhang
Jiankun Guan
Ximiao Yu
Xiaoquan Yang
Xiangliang Yang
Zifu Li
机构
[1] Huazhong University of Science and Technology,National Engineering Research Center for Nanomedicine, College of Life Science and Technology
[2] GBA Research Innovation Institute for Nanotechnology,Key Laboratory of Biomedical Photonics (HUST), Ministry of Education
[3] Huazhong University of Science and Technology,Key Laboratory of Molecular Biophysics of Ministry of Education, College of Life Science and Technology
[4] Huazhong University of Science and Technology,Hubei Key Laboratory of Bioinorganic Chemistry and Materia Medical
[5] Huazhong University of Science and Technology,Hubei Engineering Research Center for Biomaterials and Medical Protective Materials
[6] Huazhong University of Science and Technology,Hubei Bioinformatics and Molecular Imaging Key Laboratory, College of Life Science and Technology
[7] Huazhong University of Science and Technology,undefined
关键词
hydroxyethyl starch; cancer-associated fibroblasts; tumor mechanical microenvironment; cancer stem cells; combination therapy;
D O I
暂无
中图分类号
学科分类号
摘要
Cancer-associated fibroblasts (CAFs) play an important role in facilitating the progression of triple-negative breast cancer (TNBC) by deteriorating the tumor mechanical microenvironment (TMME). Herein, we designed a CAFs-targeting nanomedicine by conjugating doxorubicin (DOX)-loaded hydroxyethyl starch-IR780 nanoparticles (NPs) with Cys-Arg-Glu-Lys-Ala (CREKA) peptide, which had a special affinity for fibronectin overexpressed on CAFs. After systemic administration, the NPs efficiently targeted CAFs and generated hyperthermia upon light irradiation, decreasing CAFs through the combination of chemo- and photothermal-therapies. Thus, a series of changes in TMME were achieved by reducing CAFs, which further disrupted the niche of cancer stem cells (CSCs) to affect their survival. As a result, the tumor growth was significantly inhibited in 4T1 tumors. The strategy of TMME modulation and CSCs elimination through targeting and depleting CAFs provides a novel therapeutic treatment for desmoplastic solid tumors.
引用
收藏
页码:7323 / 7336
页数:13
相关论文
共 312 条
[11]  
Hu Y J(2018)Reengineering the physical microenvironment of tumors to improve drug delivery and efficacy: From mathematical modeling to bench to bedside Trends Cancer 4 292-795
[12]  
Chen C(2018)CD10 Cell 172 841-40
[13]  
Chen L N(2010)GPR77 Br. J. Cancer 102 789-232
[14]  
Bulle A(2020) cancer-associated fibroblasts promote cancer formation and chemoresistance by sustaining cancer stemness J. Hematol. Oncol. 13 136-1363
[15]  
Lim K H(2019)Hypoxia inducible factors in cancer stem cells Cell Stem Cell 24 25-1497.e14
[16]  
Hyun J(2020)Cancer stem cell secretome in the tumor microenvironment: A key point for an effective personalized cancer treatment Nat. Rev. Clin. Oncol. 17 204-145
[17]  
Kim H W(2020)Targeting cancer stemness in the clinic: From hype to hope Signal Transduct. Target. Ther. 5 8-962
[18]  
Taddei M L(2021)Targeting signalling pathways and the immune microenvironment of cancer stem cells—A clinical update Signal Transduct. Target. Ther. 6 218-3240
[19]  
Giannoni E(2021)Targeting cancer stem cell pathways for cancer therapy Theranostics 11 1345-1012
[20]  
Comito G(2011)Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer Gastroenterology 141 1486-77